ReachMD

Episodes 1-15 of 233

• • 

    

    Anita L. Nelson, MD

    Peer

  3

  

  RestartResume

  Individualizing Management of Endometriosis Pain: Current Evidence, Potential New Strategies, and Ongoing Research

  Individualizing Management of Endometriosis Pain: Current Evidence, Potential New Strategies, and Ongoing Research

  0.75 credits

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    Erica E. Marsh MD, MSCI, FACOG

    Peer

  5

  

  RestartResume

  Factors That Delay Diagnosis of Uterine Fibroids and Endometriosis: The Demographic Divide

  Factors That Delay Diagnosis of Uterine Fibroids and Endometriosis: The Demographic Divide

  0.25 credits

• • 

    

    Paul Paik, MD

    Peer

  • 

    

    Jyoti D. Patel, MD, FASCO

    Peer

  6

  

  RestartResume

  液体和组织活检在 NSCLC 治疗中的应用：关注 MET 基因畸变

  液体和组织活检在 NSCLC 治疗中的应用：关注 MET 基因畸变

  0.25 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    John V. Heymach, MD, PhD

    Peer

  0

  

  RestartResume

  Keeping Pace in Lung Cancer – How Would You Treat? Case-Based Learning in EGFR-Mutant NSCLC

  Keeping Pace in Lung Cancer – How Would You Treat? Case-Based Learning in EGFR-Mutant NSCLC

  0.25 credits

• • 

    

    Anita H. Clayton, MD

    Peer

  3

  

  RestartResume

  Advances in Postpartum Depression: What You Need to Know

  Advances in Postpartum Depression: What You Need to Know

  0.50 credits

• • 

    

    Paul Paik, MD

    Peer

  • 

    

    Viola Zhu, MD

    Peer

  2

  

  RestartResume

  治疗差距：识别 NSCLC 管理中的新目标

  治疗差距：识别 NSCLC 管理中的新目标

  0.25 credits

• • 

    

    Paul Paik, MD

    Peer

  • 

    

    Joshua K. Sabari, MD

    Peer

  5

  

  RestartResume

  迎接未来的全球挑战：NSCLC 控制中的病例介绍

  迎接未来的全球挑战：NSCLC 控制中的病例介绍

  0.25 credits

• • 

    

    Misako Nagasaka, MD, PhD

    Peer

  1

  

  RestartResume

  The Clinical Playbook: Team-based Integration of ADCs in Metastatic NSCLC

  The Clinical Playbook: Team-based Integration of ADCs in Metastatic NSCLC

  1.00 credits

• • 

    

    Anita L. Nelson, MD

    Peer

  2

  

  RestartResume

  Optimizing Medical Management of Uterine Fibroids: Achieving Patient-Centered Goals and Outcomes

  Optimizing Medical Management of Uterine Fibroids: Achieving Patient-Centered Goals and Outcomes

  0.75 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Edward B. Garon, MD, MS

    Peer

  1

  

  RestartResume

  Keeping Pace in Lung Cancer – All About Antiangiogenics and TKIs: Current Roles and Future Directions in EGFR-Mutant NSCLC

  Keeping Pace in Lung Cancer – All About Antiangiogenics and TKIs: Current Roles and Future Directions in EGFR-Mutant NSCLC

  0.25 credits

• • 

    

    Anita H. Clayton, MD

    Peer

  • 

    

    Nancy Byatt, DO

    Peer

  • 

    

    Jennifer L. Payne, MD

    Peer

  0

  

  RestartResume

  Perspectives on New Directions in the Management of Postpartum Depression

  Perspectives on New Directions in the Management of Postpartum Depression

  0.25 credits

• • 

    

    Roger S. McIntyre, MD, FRCPC

    Peer

  • 

    

    Martha Sajatovic, MD

    Peer

  0

  

  RestartResume

  Best Practices in the Use of Long-Acting Injectables in Bipolar Disorder – Part 1

  Best Practices in the Use of Long-Acting Injectables in Bipolar Disorder – Part 1

  0.50 credits

• • 

    

    Roger S. McIntyre, MD, FRCPC

    Peer

  • 

    

    Charles L. Raison, MD

    Peer

  0

  

  RestartResume

  Best Practices in the Use of Long-Acting Injectables in Bipolar Disorder – Part 2

  Best Practices in the Use of Long-Acting Injectables in Bipolar Disorder – Part 2

  0.50 credits

• • 

    

    Gregg C. Fonarow, MD

    Peer

  • 

    

    Andrew J. S. Coats, MD

    Peer

  1

  

  RestartResume

  Applying Key Updates from ESC/HFA to Managing Heart Failure

  Applying Key Updates from ESC/HFA to Managing Heart Failure

  0.25 credits

• • 

    

    Jeffrey S. Weber, MD, PhD

    Peer

  0

  

  RestartResume

  Optimizing Treatment Selection and Side Effect Management in BRAF-Mutant Melanoma

  Optimizing Treatment Selection and Side Effect Management in BRAF-Mutant Melanoma

  1.00 credits

• 1
• 2
• 3
• …
• 15
• 16
• Next